ResearcherKarpagam Academy of Higher EducationActive in the last 2 years
Sridhar Muthusami
Matched on ORCID iD 0000-0002-3595-9081; OpenAlex author ID A5102811252. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 3
- Unveiling the Potential Role of Hesperetin and Emodin as a Combination Therapy to Inhibit the Pancreatic Cancer Progression against the C-Met Gene. Co-author DOI 10.2174/0109298665363165250225100109↗
- Screening of MMP-2 Inhibiting Phytoconstituents for the Development of Newer Pancreatic Cancer Treatment Modalities. Last author DOI 10.2174/0929866530666230213113835↗
- Phyto-targeting the CEMIP Expression as a Strategy to Prevent Pancreatic Cancer Metastasis. Last author DOI 10.2174/1381612828666220302153201↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Muruganantham Bharathi · 3 shared papers, 2022–2025 · strength 0.77
- Paper Unveiling the Potential Role of Hesperetin and Emodin as a Combination Therapy to Inhibit the Pancreatic Cancer Progres… DOI 10.2174/0109298665363165250225100109↗
- Paper Screening of MMP-2 Inhibiting Phytoconstituents for the Development of Newer Pancreatic Cancer Treatment Modalities. DOI 10.2174/0929866530666230213113835↗
- Paper Phyto-targeting the CEMIP Expression as a Strategy to Prevent Pancreatic Cancer Metastasis. DOI 10.2174/1381612828666220302153201↗
- Loganayaki Periyasamy · 2 shared papers, 2022–2023 · strength 0.46
- Kaviyaprabha Rangaraj · 1 shared paper, 2025 · strength 0.30
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.